At a meeting hosted by the Cystic Fibrosis Foundation, private insurers, state Medicaid officials, care center providers, health experts and people with CF and their families came together to discuss innovative ways to continue improving high quality CF care on February 4.
Site Search
Showing 71 - 80 of 83 results
News
|
Feb. 23, 2015
|
2 min read
News
|
May 31, 2006
|
2 min read
News
|
Aug. 18, 2009
|
2 min read
News
|
Dec. 29, 2009
|
2 min read
Dr. Frank Accurso, director of cystic fibrosis clinical research at Children's Hospital Colorado and University of Colorado Denver, participated in a congressional roundtable discussion at National Jewish Health in Denver, Colorado.
News
|
Sept. 4, 2014
|
2 min read
News
|
April 8, 2010
|
1 min read
News
|
June 15, 2009
|
1 min read
News
|
Aug. 13, 2009
|
2 min read
News
|
July 23, 2007
|
1 min read
The U.S. Food and Drug Administration (FDA) has approved TOBI® Podhaler™ (tobramycin inhalation powder), a dry powder formulation of the antibiotic TOBI, to treat lung infections caused by the bacteria Pseudomonas aeruginosa (P. aeruginosa).
News
|
March 25, 2013
|
1 min read